Daniel Durocher

Molecular and Medical Genetics University of Toronto, Toronto, ON, Canada 
Genetics, Cell Biology, Molecular Biology, Oncology, Immunology
"Daniel Durocher"


Sign in to add mentor
Stephen P. Jackson post-doc (Neurotree)
Michael B. Yaffe post-doc MIT (Chemistry Tree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhao Y, Tabet D, Rubio Contreras D, et al. (2023) Genome-scale mapping of DNA damage suppressors through phenotypic CRISPR-Cas9 screens. Molecular Cell
Sifri C, Hoeg L, Durocher D, et al. (2023) An AlphaFold2 map of the 53BP1 pathway identifies a direct SHLD3-RIF1 interaction critical for shieldin activity. Embo Reports. e56834
De Marco Zompit M, Esteban MT, Mooser C, et al. (2022) The CIP2A-TOPBP1 complex safeguards chromosomal stability during mitosis. Nature Communications. 13: 4143
Setiaputra D, Escribano-Díaz C, Reinert JK, et al. (2022) RIF1 acts in DNA repair through phosphopeptide recognition of 53BP1. Molecular Cell
Adam S, Rossi SE, Moatti N, et al. (2021) The CIP2A-TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer. Nature Cancer. 2: 1357-1371
Feng Y, Li C, Stewart JA, et al. (2021) FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation. Nature
Sherker A, Chaudhary N, Adam S, et al. (2021) Two redundant ubiquitin-dependent pathways of BRCA1 localization to DNA damage sites. Embo Reports. e53679
Olivieri M, Cho T, Álvarez-Quilón A, et al. (2020) A Genetic Map of the Response to DNA Damage in Human Cells. Cell
Ling AK, Munro M, Chaudhary N, et al. (2020) SHLD2 promotes class switch recombination by preventing inactivating deletions within the Igh locus. Embo Reports. e49823
Álvarez-Quilón A, Wojtaszek JL, Mathieu MC, et al. (2020) Endogenous DNA 3' Blocks Are Vulnerabilities for BRCA1 and BRCA2 Deficiency and Are Reversed by the APE2 Nuclease. Molecular Cell
See more...